GlaxoSmithKline: Heart Failure trials
The registry lists 13 Heart Failure studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 5Phase 2 3Phase 3 1Phase 4 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy ParticipantsTerminatedNCT05044325Phase 1Results posted
- A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart FailureCompletedNCT02497937Phase 2Results posted
- A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac FailureCompletedNCT02135861Phase 1Results posted
- A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure PatientsCompletedNCT02119260Phase 2Results posted
- A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart FailureCompletedNCT01357850Phase 2Results posted
- A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart FailureCompletedNCT00742508Phase 1Results posted
- A Phase I Study to Assess the Pharmacokinetics of GSK2798745 TabletsCompletedNCT02925546Phase 1
- SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real WorldCompletedNCT01390935
- Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac FailureCompletedNCT01277679Phase 1
- Regulatory Nebilet PMSCompletedNCT01077661
- Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)CompletedNCT00344513Phase 4
- Effect Of GW501516X On How The Heart Obtains And Uses EnergyTerminatedNCT00318617
- COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And MicroalbuminuriaTerminatedNCT00123903Phase 3